VEGFA and gastric cancer: In vitro: Human gastric cancer cell line of SGC-7901, MKN-45, MGC-803and VEGF-stimulated MKN-45 cells. In vivo:Male BALB/c-nude mice4–6-week-old, 18 ± 2 g Administration: Dosage; 50 mg/kg of LARoute; Oral